Harpoon Therapeutics Inc
NASDAQ:HARP
Income Statement
Earnings Waterfall
Harpoon Therapeutics Inc
Revenue
|
37.3m
USD
|
Operating Expenses
|
-74.7m
USD
|
Operating Income
|
-37.4m
USD
|
Other Expenses
|
6.9m
USD
|
Net Income
|
-30.5m
USD
|
Income Statement
Harpoon Therapeutics Inc
Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||||||||||||||
Revenue |
4
N/A
|
5
+8%
|
4
-11%
|
4
N/A
|
5
+8%
|
6
+26%
|
8
+39%
|
10
+21%
|
12
+25%
|
17
+43%
|
23
+33%
|
26
+13%
|
27
+2%
|
24
-12%
|
21
-13%
|
23
+12%
|
32
+40%
|
32
-1%
|
35
+8%
|
47
+34%
|
37
-20%
|
|
Operating Income | ||||||||||||||||||||||
Operating Expenses |
(27)
|
(32)
|
(41)
|
(48)
|
(58)
|
(64)
|
(65)
|
(67)
|
(67)
|
(69)
|
(73)
|
(80)
|
(84)
|
(90)
|
(96)
|
(99)
|
(103)
|
(100)
|
(93)
|
(84)
|
(75)
|
|
Selling, General & Administrative |
(5)
|
(6)
|
(11)
|
(14)
|
(20)
|
(22)
|
(20)
|
(21)
|
(17)
|
(16)
|
(17)
|
(17)
|
(17)
|
(18)
|
(19)
|
(20)
|
(20)
|
(19)
|
(18)
|
(16)
|
(16)
|
|
Research & Development |
(22)
|
(26)
|
(30)
|
(34)
|
(38)
|
(42)
|
(45)
|
(47)
|
(50)
|
(53)
|
(56)
|
(63)
|
(67)
|
(72)
|
(77)
|
(79)
|
(83)
|
(81)
|
(76)
|
(67)
|
(59)
|
|
Operating Income |
(23)
N/A
|
(28)
-21%
|
(37)
-33%
|
(44)
-18%
|
(53)
-22%
|
(58)
-9%
|
(57)
+2%
|
(58)
-1%
|
(55)
+5%
|
(51)
+6%
|
(50)
+3%
|
(54)
-7%
|
(57)
-6%
|
(67)
-18%
|
(75)
-13%
|
(76)
-1%
|
(71)
+6%
|
(68)
+4%
|
(59)
+14%
|
(37)
+37%
|
(37)
-1%
|
|
Pre-Tax Income | ||||||||||||||||||||||
Interest Income Expense |
0
|
0
|
1
|
2
|
2
|
3
|
3
|
2
|
2
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
(0)
|
(2)
|
|
Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(50)
|
(50)
|
(50)
|
(50)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
0
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(3)
|
9
|
|
Pre-Tax Income |
(23)
N/A
|
(27)
-21%
|
(36)
-32%
|
(42)
-16%
|
(51)
-22%
|
(56)
-9%
|
(55)
+2%
|
(55)
-2%
|
(53)
+5%
|
(50)
+6%
|
(99)
-99%
|
(103)
-4%
|
(107)
-3%
|
(117)
-10%
|
(75)
+35%
|
(76)
-1%
|
(71)
+7%
|
(68)
+4%
|
(59)
+13%
|
(40)
+31%
|
(31)
+24%
|
|
Net Income | ||||||||||||||||||||||
Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Income from Continuing Operations |
(23)
|
(27)
|
(36)
|
(42)
|
(51)
|
(56)
|
(55)
|
(55)
|
(53)
|
(50)
|
(99)
|
(103)
|
(107)
|
(117)
|
(75)
|
(76)
|
(71)
|
(68)
|
(59)
|
(40)
|
(31)
|
|
Net Income (Common) |
(23)
N/A
|
(27)
-21%
|
(36)
-32%
|
(42)
-16%
|
(51)
-22%
|
(56)
-9%
|
(55)
+2%
|
(55)
-2%
|
(53)
+5%
|
(50)
+6%
|
(99)
-99%
|
(103)
-4%
|
(107)
-3%
|
(117)
-10%
|
(75)
+35%
|
(76)
-1%
|
(71)
+7%
|
(68)
+4%
|
(59)
+13%
|
(40)
+31%
|
(31)
+24%
|
|
EPS (Diluted) |
-9.45
N/A
|
-11.45
-21%
|
-14.77
-29%
|
-17.23
-17%
|
-20.83
-21%
|
-25.6
-23%
|
-21.99
+14%
|
-22.16
-1%
|
-21.04
+5%
|
-19.96
+5%
|
-31.35
-57%
|
-31.73
-1%
|
-32.67
-3%
|
-36.13
-11%
|
-22.89
+37%
|
-23
0%
|
-21.4
+7%
|
-20.42
+5%
|
-15.87
+22%
|
-10.61
+33%
|
-7.72
+27%
|